Nea 16 Gp, Llc - Net Worth and Insider Trading
Nea 16 Gp, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nea 16 Gp, Llc owns 10 companies in total, including Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , and Akouos Inc (AKUS) among others .
Click here to see the complete history of Nea 16 Gp, Llc’s form 4 insider trades.
Insider Ownership Summary of Nea 16 Gp, Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTCR | Metacrine Inc | 2020-09-15 | 10 percent owner |
GNCAQ | Genocea Biosciences Inc | 2018-01-19 | 10 percent owner |
AKUS | Akouos Inc | 2020-06-25 | 10 percent owner |
2019-05-07 | 10 percent owner | ||
2020-01-29 | 10 percent owner | ||
2017-07-24 | 10 percent owner | ||
2019-07-17 | 10 percent owner | ||
2018-10-17 | 10 percent owner | ||
2017-11-20 | 10 percent owner | ||
2018-01-19 | 10 percent owner |
Nea 16 Gp, Llc Trading Performance
Nea 16 Gp, Llc Ownership Network
Ownership Network List of Nea 16 Gp, Llc
Ownership Network Relation of Nea 16 Gp, Llc
Nea 16 Gp, Llc Owned Company Details
What does Metacrine Inc do?
Who are the key executives at Metacrine Inc?
Nea 16 Gp, Llc is the 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .
Metacrine Inc (MTCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Metacrine Inc Insider Transactions
- Download to Excel(.xls)
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Nea 16 Gp, Llc is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Nea 16 Gp, Llc is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
- Download to Excel(.xls)
What does Trevi Therapeutics Inc do?
Who are the key executives at Trevi Therapeutics Inc?
Nea 16 Gp, Llc is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .
Trevi Therapeutics Inc (TRVI) Insider Trades Summary
Over the past 18 months, Nea 16 Gp, Llc made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 7,825 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .
In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 204,544 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 204,544 shares.
Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Trevi Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Nea 16 Gp, Llc is the 10 percent owner of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Nea 16 Gp, Llc made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Nea 16 Gp, Llc is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and Chief Operating Officer Joseph P Hagan .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Nea 16 Gp, Llc made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Nea 16 Gp, Llc is the 10 percent owner of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include director & 10 percent owner Patrick J Heron , SVP & Global Controller Jolanda Howe , and Chief Scientific Officer Pamela Vig .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Nea 16 Gp, Llc made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net purchase of 162,308 shares made by Patrick J Heron , a net sale of 8,512 shares made by Jolanda Howe , and a net sale of 34,606 shares made by Pamela Vig .
In summary, during the past 3 months, insiders sold 0 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 345 shares, with a net purchase of 345 shares. During the past 18 months, 105,850 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 70,458 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Marker Therapeutics Inc do?
Who are the key executives at Marker Therapeutics Inc?
Nea 16 Gp, Llc is the 10 percent owner of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Mohamad Makhzoumi , and 10 percent owner Carmen Chang .
Marker Therapeutics Inc (MRKR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Marker Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does X4 Pharmaceuticals Inc do?
Who are the key executives at X4 Pharmaceuticals Inc?
Nea 16 Gp, Llc is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .
X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary
Over the past 18 months, Nea 16 Gp, Llc made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 601,883 shares made by Paula Ragan , a net sale of 161,480 shares made by Mary Dibiase , and a net sale of 552,345 shares made by Adam S. Mostafa .
In summary, during the past 3 months, insiders sold 660,362 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 660,362 shares. During the past 18 months, 1,626,785 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,785 shares.
X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
X4 Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Nea 16 Gp, Llc is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , EVP PHARM SCI & MFG Stapleton Raymond D Jr , and 10 percent owner Paul Edward Walker .
Genocea Biosciences Inc (GGNNQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
- Download to Excel(.xls)
Nea 16 Gp, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Nea 16 Gp, Llc. You might contact Nea 16 Gp, Llc via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey